Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

Sociedad Química y Minera de Chile

SQM

NEUTRAL

June 1, 2026

Research Conclusion

At $93.42/ADR, SQM trades at the upper end of a $50–95 defensible range. Conservative model implies fair value $55–75 (20–40% overvalued); consensus read implies fair value $80–110 (approximately fair). The asymmetric upside from the $45 trough entry point has substantially closed. Existing holders should not add at current prices; new entrants should wait for a pullback to $55–65 to restore favorable asymmetry. Probability-weighted expected return: –28%. The critical unresolved variable is Nova Andino capital-recovery treatment, which alone could swing DCF by $30–40/ADR.

Company Overview & Moat Assessment

Sociedad Química y Minera de Chile (SQM) is the world's second-largest lithium producer and the dominant global producer of iodine and specialty plant nutrition (potassium nitrate). Operations are centered on Chile's Salar de Atacama — the highest-grade, lowest-cost lithium brine deposit on Earth, yielding $3,000–5,000/t all-in lithium cash cost. Following the May 2024 Nova Andino Litio JV with Codelco, the Chilean state captures ~70% of Atacama operating margin 2025–2030 (SQM keeps ~30%) and ~85% from 2031–2060 (SQM keeps ~15%) in exchange for 30-year mining-rights extension to 2060. Non-lithium businesses provide a structural $800M–1.0B EBITDA floor independent of the lithium cycle. Market cap ~$26B; investment-grade balance sheet (Moody's Baa1, S&P BBB+).

▲ Bull Case

  • ◆Chinese lepidolite permanently exits while Argentine brine ramps slowly; Li prices sustain $20–25K/t through 2030, driving SQM EBITDA to $3.0–3.5B by 2028; target $115–130/ADR (+23–39% upside).
  • ◆Capex delivers on schedule enabling 300kt+ production in 2027 with iodine sustained at $70+/kg, multiplying through cycle-peak margins; SOTP valuation supports $83–95/ADR.
  • ◆SQM negotiates improved post-2031 economics (25–30% vs. 15% baseline) as Codelco transition approaches, materially lifting terminal value and intrinsic worth.

▼ Bear Case

  • ◆Chinese government implicitly subsidizes lepidolite while Argentine brine adds 150kt by 2028; Li stagnates at $9–12K/t, capping SQM EBITDA at $850M–1.1B; target $25–40/ADR (–57 to –73% downside).
  • ◆SEIA environmental permit is materially restricted or denied (30–35% probability), capping expansion at 220–250kt and breaking volume thesis; impact –$10–15/ADR even in benign price scenarios.
  • ◆Post-Boric Chilean government renegotiates Nova Andino outside contract process; Tianqi forced stake sale creates overhang; capex cut to maintenance; impact ~70% drawdown.
Primary Debate on Wall Street

“The market pivots on three unresolved questions: (1) Is the H2 2025 Li price recovery cyclical (priced in) or structural (more upside)? Bulls cite EV penetration and grid storage emergence; bears cite lepidolite supply elasticity and Argentine ramp. (2) How much of SQM's pre-2031 economic share (30% vs. 70% Codelco take) is the market pricing? Bulls emphasize the 5-year operating window; bears argue the market double-counts upside that should be valued only through 2030. (3) What is the right cycle multiple? Mining cyclicals historically trade 6–12x EV/EBITDA; at 8–9x consensus EBITDA, current valuation is defensible only if peak earnings sustain — which prior cycles suggest is rare. Consensus rating: Buy (10 analysts), average target $68.80 (range $50–$100), median ~$77 — well below current $93.”

Top Catalysts
  • ◆Chinese lepidolite permanent exit confirmed (2026–2027): +15–20% upside if structural oversupply resolved
  • ◆SEIA expansion permit approval (H1 2026 filing, 2027 decision): +8–12% upside to enable 300kt+ production run-rate
  • ◆Li carbonate sustained >$14K/t for 60+ days (Q3–Q4 2026): +10–15% upside; signals cycle durability
  • ◆US-Chile critical minerals agreement finalized: +10–15% upside; strengthens geopolitical positioning
  • ◆Codelco renegotiates post-2031 terms upward (2029–2031): +$15–20/ADR terminal value lift
Top Risks
  • ◆Prolonged Li price depression (<$10K/t sustained): 15–20% probability; impact –30 to –50% from current price; non-Li floor at ~$25/ADR provides mitigation
  • ◆Post-2031 Nova Andino governance deterioration or Codelco takeover at disadvantageous terms: 35–40% probability; impact –15–25% terminal value
  • ◆SEIA permit delay, denial, or material environmental restrictions: 30–35% probability; impact –$0.5–1.5B NPV; –8–12% stock impact
  • ◆Chilean government contract renegotiation outside formal process: 8–12% probability; impact severe (–50%+); international BIT protection provides legal mitigation
  • ◆Tianqi forced stake sale to Chinese state-aligned entity: 15–20% probability; impact –10–15% near-term overhang; potential forced break-up

Full Memo Continues

5 more sections, locked

  • ●
    Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • ●
    Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • ●
    Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • ●
    Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • ●
    Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/SQM/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.